News & events
US reference laboratory completes ASTar® evaluation
Q-linea further expands US commercial team
Q-linea AB (publ) (OMX: QLINEA) today announces the appointment of a new corporate account manager in the US marketThis...
Read more >
Q-linea announces changes in executive leadership team
Q-linea AB (publ) (OMX: QLINEA) today announces that Franco Pellegrini has been appointed VP Sales EMEA at Q-linea as...
Read more >
Q-linea enters the Middle East region through partnership with AMICO Group
Q-linea AB (publ) (OMX: QLINEA) today announces that the company is expanding into the Middle East through an exclusive...
Read more >
Recorded webinar: Clinical Evaluation of an FDA-Cleared High-Throughput Rapid Antibiotic Susceptibility Testing System
Two leading US microbiology labs present interim evaluation data on webinar
Q-linea AB (publ) (OMX:QLINEA) announces webinar titled “Clinical Evaluation of an FDA-Cleared High-Throughput Rapid Antibiotic Susceptibility Testing System” hosted...
Read more >
Q-linea enters into distribution agreement with S.C. Mecro System S.R.L.
CMS grants New Technology Add-on Payment (NTAP) for ASTar®
Load more